📣 VC round data is live. Check it out!

Precipio Valuation Multiples

Discover revenue and EBITDA valuation multiples for Precipio and similar public comparables like BGSF, Staffline Group, Gattaca, Dedicare and more.

Precipio Overview

About Precipio

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.


Founded

1997

HQ

United States

Employees

60

Financials (FY)

Revenue: $24M
EBITDA: $1M

EV

$54M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Precipio Financials

Precipio reported last fiscal year revenue of $24M and EBITDA of $1M.

In the same fiscal year, Precipio generated $11M in gross profit, $1M in EBITDA, and had net loss of ($363K).


Precipio P&L

In the most recent fiscal year, Precipio reported revenue of $24M and EBITDA of $1M.

Precipio is unprofitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 6%, and net margin of (2%).

See analyst estimates for Precipio
Last FY202320242025202620272028
Revenue$24M$15M$19M$24M
Gross Profit$11M$6M$8M$11M
Gross Margin45%40%41%45%
EBITDA$1M($4M)($3M)$1M
EBITDA Margin6%(28%)(15%)6%
EBIT Margin(5%)(50%)(23%)(5%)
Net Profit($363K)($6M)($4M)($363K)
Net Margin(2%)(39%)(23%)(2%)

Financial data powered by Morningstar, Inc.

Precipio Stock Performance

Precipio has current market cap of $53M, and enterprise value of $54M.


Precipio's stock price is $29.81.

Precipio has an EPS (earnings per share) of $-0.20.

See more trading valuation data for Precipio
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$54M$53M0.0%$-0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Precipio Valuation Multiples

Precipio trades at 2.3x EV/Revenue multiple, and 37.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Precipio

Precipio Financial Valuation Multiples

As of May 10, 2026, Precipio has market cap of $53M and EV of $54M.

Precipio has a P/E ratio of (146.6x).

Last FY202320242025202620272028
EV/Revenue2.3x3.6x2.9x2.3x
EV/EBITDA37.1x(12.6x)(20.1x)37.1x
EV/EBIT(45.1x)(7.1x)(12.9x)(45.1x)
EV/Gross Profit5.1x9.0x7.2x5.1x
P/E(146.6x)(9.1x)(12.4x)(146.6x)
EV/FCF151.0x(14.7x)n/m151.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Precipio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Precipio Margins & Growth Rates

In the most recent fiscal year, Precipio reported gross margin of 45%, EBITDA margin of 6%, and net margin of (2%).

See estimated margins and future growth rates for Precipio

Precipio Margins

Last FY20242025202720282029
Gross Margin45%41%45%
EBITDA Margin6%(15%)6%
EBIT Margin(5%)(23%)(5%)
Net Margin(2%)(23%)(2%)
FCF Margin1%1%1%

Precipio Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth22%30%
Gross Profit Growth26%42%
EBITDA Growth(37%)(154%)
EBIT Growth(45%)(71%)
Net Profit Growth(27%)(92%)
FCF Growth(106%)66%

Data powered by FactSet, Inc. and Morningstar, Inc.

Precipio Operational KPIs

Precipio's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Precipio
Last FY202320242025202620272028
Revenue per Employee$0.4M
Opex per Employee$0.2M
Opex to Revenue50%90%64%50%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Precipio Competitors

Precipio competitors include BGSF, Staffline Group, Gattaca, Dedicare, Peoplein, Freelancer, Wantedly, Administer, Ogunsen and eSense Human Resources.

Most Precipio public comparables operate across Recruitment & Staffing.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
BGSF0.4x0.4x(5.2x)
Staffline Group0.0x0.0x2.8x2.7x
Gattaca0.1x0.1x5.1x3.9x
Dedicare0.2x5.1x
Peoplein0.1x0.1x3.2x4.7x
Freelancer0.8x0.9x5.2x6.2x
Wantedly0.7x0.8x2.2x
Administer0.6x0.5x7.0x6.6x

This data is available for Pro users. Sign up to see all Precipio competitors and their valuation data.

Start Free Trial

Precipio Funding History

Before going public, Precipio raised $2M in total equity funding, across 1 round.


Precipio Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Oct-13Series BAdvantage Capital; Connecticut Innovations; Eli Whitney Fund; Enhanced Capital Partners; Ironwood Capital; Kuzari Group$2M

Precipio M&A Activity

Precipio has acquired 1 company to date.

Last acquisition by Precipio was on October 13th 2016. Precipio acquired Transgenomic for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Precipio

Transgenomic
Description
Transgenomic is a global biotechnology firm offering molecular diagnostics, genetic testing, and research services in cardiology, oncology, neurology, and mitochondrial disorders. Its divisions include clinical laboratories, pharmacogenomic services for drug trials, and diagnostic tools like the C-GAAP cardiac test. Serving over 50 countries, the company acquired Clinical Data's diagnostics in 2010 and operates from New Haven, Connecticut.
HQ CountryUnited States
HQ City
Omaha, NE
Deal Date13 Oct 2016
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Precipio acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Precipio

When was Precipio founded?Precipio was founded in 1997.
Where is Precipio headquartered?Precipio is headquartered in United States.
How many employees does Precipio have?As of today, Precipio has over 60 employees.
Is Precipio publicly listed?Yes, Precipio is a public company listed on Nasdaq.
What is the stock symbol of Precipio?Precipio trades under PRPO ticker.
When did Precipio go public?Precipio went public in 2000.
Who are competitors of Precipio?Precipio main competitors include BGSF, Staffline Group, Gattaca, Dedicare, Peoplein, Freelancer, Wantedly, Administer, Ogunsen, eSense Human Resources.
What is the current market cap of Precipio?Precipio's current market cap is $53M.
What is the current revenue of Precipio?Precipio's last fiscal year revenue is $24M.
What is the current EV/Revenue multiple of Precipio?Current revenue multiple of Precipio is 2.3x.
Is Precipio profitable?No, Precipio is not profitable.
How many companies Precipio has acquired to date?As of May 2026, Precipio has acquired 1 company.
What was the largest acquisition by Precipio?None of the M&A deals Precipio has completed have disclosed valuations.
What companies Precipio acquired?Precipio acquired Transgenomic.
In how many companies Precipio has invested to date?Precipio hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Precipio

Lists including Precipio

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial